$0.87
+0.05 (+5.75%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+3,787.8% upside
Low Target
$19.62
Average Target
$33.96
High Target
$35.69
Current Price
$0.87
Current
$0.87
$0.87
Target
$33.96
$33.96
$19.62
$33.96 avg
$35.69
Scenario Analysis
Bear Case
$19.62
2,146.1%
Low target
Base Case
$33.96
+3,787.8%
Avg target
Bull Case
$35.69
+3,985.9%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$1.80
-51.5% from high
52-Week Low
$0.75
+16.5% from low
Target vs 52W High
$33.96
+1,786.7% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.9% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |